HDT Bio Canada Inc. partners with McGill University and The Neuro to advance HDT-401, an investigational locally administered RNA immune activator, into Phase 1 clinical evaluation for glioblastoma in Canada MONTREAL and SEATTLE, July 12, 2026 /PRNewswire/ -- Among the deadliest of brain cancers, glioblastoma kills virtually everyone diagnosed, and usually within 15 months. Decades of research have produced virtually no improvement. No approved immunotherapy has ever demonstrated a survival bene

New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partners TOKYO and CAMBRIDGE, Mass., July 12, 2026 /PRNewswire/ -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that new data presented at the Alzheimer's Association International Conference® (AAIC®) 2026 in London support that the LEQEMBI® (lecanemab) subcutaneous autoinjector (SC-AI) formulation offers effi

The new data demonstrates the potential to improve control of acute infection, latency, and viral reactivation, further supporting the concept behind EVX-V1EVX-V1 is a next-generation, multi-component vaccine program combining novel AI-discovered antigens with AI-optimized versions of established CMV vaccine antigensData presented today in poster presentation at the International Herpesvirus Workshop 2026 taking place in Montreal, Canada COPENHAGEN, Denmark, July 12, 2026 - Evaxion A/S (NASDAQ:

HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater than or equal to 2.4-fold peak increases in Von Willebrand Factor (VWF) and Factor VIII (FVIII), normalization of peak thrombin generation and activated partial thromboplastin time (APTT), and durability supporting potential monthly subcutaneous dosing HMB-003 program announced as non-hormonal direct plasmin inhibitor with potent, selective and extended antifibrinolytic activity, designed to reduce bleeding acros

FORMER ELITE SOCCER PLAYERS SHOW EVIDENCE OF BRAIN HEALTH CHANGES IN MID-LIFE Key Takeaways New research provides insights into brain health among former elite professional soccer players during midlife. Former players reported high levels of depression, anxiety, and subjective difficulties with thinking and decision-making. Researchers found brain differences that warrant further study. The findings highlight the need for long-term monitoring and further research into the effects of repetitiv

A simple, non-invasive ultrasound treatment could one day help injured joints heal instead of remaining trapped in a cycle of damaging inflammation. Researchers at The University of Alabama in Huntsville found that continuous low-intensity ultrasound encouraged key immune cells called macrophages to shift from an inflammatory state toward one that supports tissue repair.Researchers at The University of Alabama in Huntsville (UAH), part of The University of Alabama System, have identified a promi

Researchers found that tau is essential for turning new experiences into lasting memories by helping organize the brain's memory-storing cells. The mouse study also revealed how abnormal tau may contribute to Alzheimer's by disrupting both the formation of new memories and the recall of existing ones.New research has revealed that tau, a protein best known for its connection to Alzheimer's disease, is also essential for creating long lasting memories. The discovery provides new insight into how

North India's leading home healthcare provider marks the milestone while investing in AI to make trustworthy medical guidance more accessible. Technology and AI are letting us scale trustworthy healthcare guidance in a way that wasn't possible two years ago. And we are allowing FREE access to all content.” — Saket has over three Decades of professional & Investment experience. DELHI, DELHI, INDIA, July 11, 2026 / EINPresswire.com / -- Healthy Jeena Sikho (HJS) today announced its educational hea

The Food and Drug Administration July 10 released a proposed rule that would modernize drug establishment registration requirements, with implications for pharmaceutical manufacturers and health systems that depend on a stable medication supply chain. The proposal would create a streamlined registration process for distributed manufacturing operations that use a “hub-and-spoke” model, allowing qualifying networks to register as a single establishment rather than registering each manufacturing un

Presented interim FRONTIER4 data evaluate the long-term safety and efficacy of investigational denecimig across once-weekly, once-every-two-weeks, and once-monthly dosing in hemophilia A participants of all ages and disease severities1,2 Denecimig is an investigational subcutaneous FVIIIa-mimetic antibody under review with the US Food and Drug Administration (FDA)1 Separate phase 3 explorer10 data observed that concizumab reduced annualized bleeding rate compared to on-demand treatment in childr